The mechanism of action of radiosensitization of conventional chemotherapeutic agents
- 1 January 2003
- journal article
- review article
- Published by Elsevier in Seminars in Radiation Oncology
- Vol. 13 (1) , 13-21
- https://doi.org/10.1053/srao.2003.50002
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- ERCC1 and Thymidylate Synthase mRNA Levels Predict Survival for Colorectal Cancer Patients Receiving Combination Oxaliplatin and Fluorouracil ChemotherapyJournal of Clinical Oncology, 2001
- Recent advances in the use of radiosensitizing nucleosidesSeminars in Radiation Oncology, 2001
- HPV16-E7 Expression Causes Fluorodeoxyuridine-mediated Radiosensitization in SW620 Human Colon Cancer CellsNeoplasia, 1999
- The effect of activation of wild-type p53 function on fluoropyrimidine-mediated radiosensitizationInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Fluoropyrimidine-radiation interactions in cells and tumorsSeminars in Radiation Oncology, 1997
- Effect of p53 overexpression on radiation sensitivity of human colon cancer cellsRadiation Oncology Investigations, 1997
- Fluorodeoxyuridine-mediated cytotoxicity and radiosensitization require S phase progressionInternational Journal of Radiation Biology, 1996
- Immortalization of distinct human mammary epithelial cell types by human papilloma virus 16 E6 or E7.Proceedings of the National Academy of Sciences, 1995
- A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.Journal of Clinical Oncology, 1991
- Saturation of 2?, 2?-difluorodeoxycytidine 5?-triphosphate accumulation by mononuclear cells during a phase I trial of gemcitabineCancer Chemotherapy and Pharmacology, 1991